Spiropiperidyl rifabutins: expanded in vitro testing against ESKAPE pathogens and select bacterial biofilms
Publication date:
2020
Publisher version:
Citación:
Journal of Antibiotics, 73, p. 868-872 (2020); doi:10.1038/s41429-020-0346-x
Descripción física:
p. 868-872
ISSN:
Patrocinado por:
Financial support by Asturpharma S.A. and the projects PC-CIS01-22 (FICYT) and PR-01-GE-9 (Grupo de Excelencia FICYT) from the Consejería de Educación y Cultura del Principado de Asturias, and by Banco de Santander-Universidad de Oviedo (CEI “Ad Futurum” 10.01.633B.481.60) is gratefully acknowledged. This work was also supported in part by the National Institute of Allergy and Infectious Diseases, National Institutes of Health under award numbers AI151970 (T.E.L) and AI124458 (L.N.S.).
Collections
- Artículos [37321]
Files in this item
Métricas
Compartir
